Pharma

Partner Content
Launch-Excellence-2020_WEB_FULL_COVER (1)
Partner Content

Launch Excellence 2020

In the past year, the competition in biosimilars and complex generics has complicated the launch landscape.

Partner Content
immune-system-1132182_1920 (1)
Partner Content

Understanding the evolving CAR-T market

In August 2017, Novartis made history after receiving FDA approval for Kymriah, the world’s first chimeric antigen receptor T-cell (CAR-T) therapy.